M. Iyengar

发表

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

D. Sheehan, K. Rickels, Karl Rickels, 2003, The American journal of psychiatry.

Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.

A. Rapoport, R. Amado, L. Melchiori, 2019, Blood advances.

Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease: A Meta-Analysis of Randomized Trials

G. Beck, A. Cheung, T. Berl, 2011, Circulation. Heart failure.

The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.

P. Raskin, Jackson T. Wright, J. McGill, 2005, Journal of diabetes and its complications.

Lowering Blood Pressure With β‐Blockers in Combination With Other Renin‐Angiotensin System Blockers in Patients With Hypertension and Type 2 Diabetes: Results From the GEMINI Trial

P. Raskin, Jackson T. Wright, J. McGill, 2007, Journal of clinical hypertension.

Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.

P. Novotny, J. Sloan, J. Lovato, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of a Once‐Daily Formulation of Carvedilol for the Treatment of Hypertension

G. Bakris, D. Sica, Michael A. Weber, 2006, Journal of clinical hypertension.

Non‐cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy

K. Reddy, E. Giannini, M. Romero-Gómez, 2015, Journal of gastroenterology and hepatology.

Effect of Combining Extended‐Release Carvedilol and Lisinopril in Hypertension: Results of the COSMOS Study

G. Bakris, P. Ordronneau, M. Iyengar, 2010, Journal of clinical hypertension.

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.

V. Stearns, M. Iyengar, K. Beebe, 2003, JAMA.

Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.

K. Rickels, M. Rynn, M. Iyengar, 2006, The Journal of clinical psychiatry.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

M. Pollack, A. Goddard, R. Zaninelli, 2001, The Journal of clinical psychiatry.

A phase I/IIa, open label, clinical trial evaluating the safety and efficacy of autologous T cells expressing enhanced TCRs specific for NY-ESO-1 in patients with recurrent or treatment refractory ovarian cancer (NCT01567891).

A. Jazaeri, K. Odunsi, G. Kari, 2017 .

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

G. Demetri, S. Grupp, B. V. Van Tine, 2019, Journal of Immunotherapy for Cancer.

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

J. Bussel, F. Locatelli, D. Pospíšilová, 2015, The Lancet.

Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.

J. Bussel, V. Blanchette, L. Krishnamurti, 2015, The Lancet. Haematology.

Controlled-release carvedilol in the treatment of essential hypertension.

G. Bakris, D. Sica, M. Iyengar, 2006, The American journal of cardiology.

Meta-analysis of outcome studies in end-stage renal disease

M. Kvasz, S. Mujais, S. Ross, 2000 .

β‐Blocker use and diabetes symptom score: results from the GEMINI study

P. Raskin, J. McGill, G. Bakris, 2007, Diabetes, obesity & metabolism.

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

P. Raskin, J. McGill, G. Bakris, 2008, Journal of the cardiometabolic syndrome.

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.

U. Lepola, F. Stocchi, H. Bryson, 2003, The Journal of clinical psychiatry.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

D. Sheehan, M. Iyengar, D. Burnham, 2005, The Journal of clinical psychiatry.

Phase I/IIa Study of Genetically Engineered NY-ESO-1 SPEAR T-Cells Administered Following Autologous Stem Cell Transplant in HLA-a*02+ Patients with Advanced Multiple Myeloma: Long Term Follow-up (NCT01352286)

A. Rapoport, R. Amado, E. Stadtmauer, 2017 .

Paroxetine controlled release was effective and tolerable for treating menopausal hot flash symptoms in women

V. Stearns, M. Iyengar, P. Lotke, 2004 .

Importance of blood pressure control in left ventricular mass regression.

N. Reichek, G. Bakris, M. G. St. John Sutton, 2010, Journal of the American Society of Hypertension : JASH.

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

J. Bussel, V. Blanchette, F. Locatelli, 2014 .

Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.

R. Lydiard, M. Rapaport, M. Iyengar, 2009, The Journal of clinical psychiatry.

COMPOSITIONAL TIME SERIES ANALYSIS OF MORTALITY PROPORTIONS

Nalini Ravishanker, Dipak K. Dey, D. Dey, 2001 .